Brief: Sino Biopharmaceutical Recommends Payment Of Final Dividend Of HK4 Cents Per Share
20/03/2025 08:33
March 20 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK: RECOMMENDED PAYMENT OF A FINAL DIVIDEND OF HK4 CENTS PER SHARE FOR YEAR FY PROFIT ATTRIBUTABLE RMB3.50 BILLION FY REVENUE RMB28.87 BILLION Further company coverage: 1177.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit